These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7643205)

  • 1. Neuropeptides phase shift the mammalian circadian pacemaker.
    Piggins HD; Antle MC; Rusak B
    J Neurosci; 1995 Aug; 15(8):5612-22. PubMed ID: 7643205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the phase shifting effects of gastrin releasing peptide when microinjected into the suprachiasmatic region.
    Albers HE; Gillespie CF; Babagbemi TO; Huhman KL
    Neurosci Lett; 1995 May; 191(1-2):63-6. PubMed ID: 7659293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicuculline increases and muscimol reduces the phase-delaying effects of light and VIP/PHI/GRP in the suprachiasmatic region.
    Gillespie CF; Huhman KL; Babagbemi TO; Albers HE
    J Biol Rhythms; 1996 Jun; 11(2):137-44. PubMed ID: 8744241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of colocalized neuropeptides: functional significance in the circadian timing system.
    Albers HE; Liou SY; Stopa EG; Zoeller RT
    J Neurosci; 1991 Mar; 11(3):846-51. PubMed ID: 2002363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in colocalization between Fos and PHI, GRP, VIP and VP in neurons of the rat suprachiasmatic nucleus after a light stimulus during the phase delay versus the phase advance period of the night.
    Romijn HJ; Sluiter AA; Pool CW; Wortel J; Buijs RM
    J Comp Neurol; 1996 Aug; 372(1):1-8. PubMed ID: 8841917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA(A) and GABA(B) agonists and antagonists alter the phase-shifting effects of light when microinjected into the suprachiasmatic region.
    Gillespie CF; Mintz EM; Marvel CL; Huhman KL; Albers HE
    Brain Res; 1997 Jun; 759(2):181-9. PubMed ID: 9221935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic activity modulates the phase-shifting effects of gastrin-releasing peptide and light.
    Kallingal GJ; Mintz EM
    Eur J Neurosci; 2006 Nov; 24(10):2853-8. PubMed ID: 17156209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase shifts to light are altered by antagonists to neuropeptide receptors.
    Chan RK; Sterniczuk R; Enkhbold Y; Jeffers RT; Basu P; Duong B; Chow SL; Smith VM; Antle MC
    Neuroscience; 2016 Jul; 327():115-24. PubMed ID: 27090819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase.
    Kallingal GJ; Mintz EM
    Neurosci Lett; 2007 Jul; 422(1):59-63. PubMed ID: 17597298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro.
    Reed HE; Meyer-Spasche A; Cutler DJ; Coen CW; Piggins HD
    Eur J Neurosci; 2001 Feb; 13(4):839-43. PubMed ID: 11207820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of photic shifts with the 5-HT1A mixed agonist/antagonist NAN-190: intra-suprachiasmatic nucleus pathway.
    Sterniczuk R; Stepkowski A; Jones M; Antle MC
    Neuroscience; 2008 May; 153(3):571-80. PubMed ID: 18406538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrin-releasing peptide phase-shifts suprachiasmatic nuclei neuronal rhythms in vitro.
    McArthur AJ; Coogan AN; Ajpru S; Sugden D; Biello SM; Piggins HD
    J Neurosci; 2000 Jul; 20(14):5496-502. PubMed ID: 10884333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the role of substance P in photic responses of the circadian system: individual and combined actions with gastrin-releasing peptide.
    Sterniczuk R; Colijn MA; Nunez M; Antle MC
    Neuropharmacology; 2010 Jan; 58(1):277-85. PubMed ID: 19540856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of microinjections of substance P into the suprachiasmatic nucleus region on hamster wheel-running rhythms.
    Piggins HD; Rusak B
    Brain Res Bull; 1997; 42(6):451-5. PubMed ID: 9128920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted circadian rhythms in VIP- and PHI-deficient mice.
    Colwell CS; Michel S; Itri J; Rodriguez W; Tam J; Lelievre V; Hu Z; Liu X; Waschek JA
    Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R939-49. PubMed ID: 12855416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of nocturnal and diurnal rodents.
    Dardente H; Menet JS; Challet E; Tournier BB; Pévet P; Masson-Pévet M
    Brain Res Mol Brain Res; 2004 May; 124(2):143-51. PubMed ID: 15135222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of aging and chronic fluoxetine treatment on circadian rhythms and suprachiasmatic nucleus expression of neuropeptide genes and 5-HT1B receptors.
    Duncan MJ; Hester JM; Hopper JA; Franklin KM
    Eur J Neurosci; 2010 May; 31(9):1646-54. PubMed ID: 20525077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of pressure-ejected bombesin-like peptides on hamster suprachiasmatic nucleus neurons in vitro.
    Piggins HD; Rusak B
    J Neuroendocrinol; 1993 Oct; 5(5):575-81. PubMed ID: 8680427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An essential role for peptidergic signalling in the control of circadian rhythms in the suprachiasmatic nuclei.
    Harmar AJ
    J Neuroendocrinol; 2003 Apr; 15(4):335-8. PubMed ID: 12622830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-releasing peptide induces c-Fos in the hamster suprachiasmatic nucleus.
    Piggins HD; Goguen D; Rusak B
    Neurosci Lett; 2005 Aug; 384(3):205-10. PubMed ID: 15955628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.